Advertisement

Pharmacy World & Science

, Volume 31, Issue 2, pp 195–201 | Cite as

Resident physician and hospital pharmacist familiarity with patient discharge medication costs

  • Kerry WilburEmail author
Research Article

Abstract

Objective Cost-related medication non-adherence is associated with increased health-care resource utilization and poor patient outcomes. Physicians-in-training generally receive little education regarding costs of prescribed therapy and may rely on hospital pharmacists for this information. However, little is documented regarding either of these health care providers’ familiarity with out-of pocket medication expenses borne by patients in the community. The purpose of this study was to evaluate and compare resident physician and hospital pharmacist familiarity with what patients pay for medications prescribed once discharged. Setting A major tertiary patient care and medical teaching centre in Canada. Method Internal medicine residents and hospital pharmacists within a specific health care organization were invited to participate in an online survey. Eight patient case scenarios and associated discharge therapeutic regimens were outlined and respondents asked to identify the costs patients would incur when having the prescription filled once discharged. Main Outcome Measure Total number and proportion of estimates above and below actual cost were calculated and compared between the groups using χ2 tests. Responses ±10% of the true cost were considered correct. Mean absolute values and standard deviation estimated costs, as well as cost increments above and below 10%, were calculated to assess the magnitude of the discrepancy between the respondent estimates and the actual total cost. Results Forty-four percent of physician residents and 26% of hospital pharmacists accessed the survey. Overall 39% and 47% of medication costs were under-estimated, 32% and 33% were overestimated, and 29% and 21% were correctly estimated by residents and pharmacists, respectively (P = NS). Incorrect estimates were evident across all therapeutic classes and medical indications presented in the survey. The greatest absolute cost discrepancy for both groups was under-estimation of linezolid ($800 and $400) and over-estimation of clopidogrel ($80) and bisoprolol therapy ($22) by residents and pharmacists, respectively. Conclusion Resident physicians and hospital pharmacists are unfamiliar with what patients must pay for drug therapy once discharged.

Keywords

Canada Costs Discharge medication Pharmacist Resident physician 

Notes

Acknowledgements

All pharmacists and resident physicians who participated in the survey.

Funding

No special funding was obtained for this study.

Conflict of interest

The author has no conflicts of interest to declare.

References

  1. 1.
    Canadian Institute for Health Information. Drug Expenditure in Canada 1985–2007. Ottawa: CIHI; 2008.Google Scholar
  2. 2.
    Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv. 2004;34(1):101–22. doi: 10.2190/4M3E-L0YF-W1TD-EKG0.PubMedCrossRefGoogle Scholar
  3. 3.
    Grootendorst P. Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment. Can J Clin Pharmacol. 2002;9(2):79–99.PubMedGoogle Scholar
  4. 4.
    Leibowitz A, Manning WG, Newhouse JP. The demand for prescription drugs as a function of cost-sharing. Soc Sci Med. 1985;21(10):1063–9. doi: 10.1016/0277-9536(85)90161-3.PubMedCrossRefGoogle Scholar
  5. 5.
    Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, et al. Cost-related medicaton non-adherence among elderly and disabled medicare beneficiaries. A national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166(17):1829–35. doi: 10.1001/archinte.166.17.1829.PubMedCrossRefGoogle Scholar
  6. 6.
    Lillard La, Rogowski J, Kingston R. Insurance coverage for prescription drugs: effects on use and expenditures in the medicare population. Med Care. 1999;37(9):926–36. doi: 10.1097/00005650-199909000-00008.PubMedCrossRefGoogle Scholar
  7. 7.
    Steinman M, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. A national survey. J Gen Intern Med. 2001;16(12):793–9. doi: 10.1046/j.1525-1497.2001.10412.x.PubMedCrossRefGoogle Scholar
  8. 8.
    Piette JD, Heisler M, Wagner TH. Cost-related medication underuse. Do patients with chronic illness tell their doctors? Arch Intern Med. 2004;164(16):1749–55. doi: 10.1001/archinte.164.16.1749.PubMedCrossRefGoogle Scholar
  9. 9.
    Urquhart J. Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens. Pharmacoeconomics. 1999;15(3):317–28. doi: 10.2165/00019053-199915030-00002.CrossRefGoogle Scholar
  10. 10.
    Cleemput I, Kesteloot K. Economic implications of non-compliance in health care. Lancet. 2002;359(9324):2129–30. doi: 10.1016/S0140-6736(02)09114-6.PubMedCrossRefGoogle Scholar
  11. 11.
    Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421–9. doi: 10.1001/jama.285.4.421.PubMedCrossRefGoogle Scholar
  12. 12.
    Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin TJ, Choodnovskkiy I. Effects of medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325(15):1072–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Russell LB, Wolff N. The impact of drug pricing policies on the health of the elderly. Am J Prev Med. 2002;22(3):151–5. doi: 10.1016/S0749-3797(01)00432-9.PubMedCrossRefGoogle Scholar
  14. 14.
    Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Lix E, et al. When patients have to pay a share of drug costs. Effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ. 2005;173(11):1335–40.PubMedGoogle Scholar
  15. 15.
    Hsu J, Price M, Huang J, Brand R, Fung V, Hui R, et al. Unintended consequences of caps on medicare drug benefits. N Engl J Med. 2006;354(22):2349–59. doi: 10.1056/NEJMsa054436.PubMedCrossRefGoogle Scholar
  16. 16.
    Hoffman J, Barefield FA, Ramamurthy S. A survey of physician knowledge of drug costs. J Pain Symptom Manag. 1995;10(6):432–5. doi: 10.1016/0885-3924(95)00018-T.CrossRefGoogle Scholar
  17. 17.
    Weber ML, Auger C, Cleroux R. Knowledge of medical students, pediatric residents, and pediatricians about the cost of some medications. Pediatr Pharmacol (New York). 1986;5(4):281–5.Google Scholar
  18. 18.
    Heisler M, Wagner TH, Piette JD. Clinician identification of chronically ill patients who have problems paying for prescript ion medications. Am J Med. 2004;116(11):753–8. doi: 10.1016/j.amjmed.2004.01.013.PubMedCrossRefGoogle Scholar
  19. 19.
    Shrank WH, Asch SM, Joseph GJ, Young HN, Ettner SL, Kholodenko Y, et al. Physician’s perceived knowledge of and responsibility for managing patients’ out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006;40(9):1534–40. doi: 10.1345/aph.1H158.PubMedCrossRefGoogle Scholar
  20. 20.
    The Canadian Press. Doctors’ knowledge of drug prices could lower health costs: study (Online) 2007. http://www.cbc.ca/health/story/2007/10/22/doctors-precriptionstudy.html. Accessed 22 Oct 2007.
  21. 21.
    Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9):1486–96. doi: 10.1371/journal.pmed.0040283.CrossRefGoogle Scholar
  22. 22.
    Taxis k, Schneeweiss S. Frequency and predictors of drug therapy interruptions after hospital discharge under physician drug budgets in Germany. Int J Clin Pharmacol Ther. 2003;41(2):77–82.PubMedGoogle Scholar
  23. 23.
    McCormack PME, Feely J. The impact of hospitalization on prescribing costs for medical patients returning to the community. Ir Med J. 1997;90(3):99–100. Apr May.PubMedGoogle Scholar
  24. 24.
    Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. Eur J Heart Fail. 2004;6(2):235–43.PubMedCrossRefGoogle Scholar
  25. 25.
    O’Connor PJ. Improving medication adherence. Challenges for physicians, payers, and policy makers. Arch Intern Med. 2006;166(17):1802–4. doi: 10.1001/archinte.166.17.1802.PubMedCrossRefGoogle Scholar
  26. 26.
    Allan GM, Innes G. Family practice residents’ awareness of medical care costs in British Columbia. Fam Med. 2002;34(2):104–9.PubMedGoogle Scholar
  27. 27.
    Conti G, Delll”Utri D, Pelaia P, Rosa G, Cogliati AA, Gasparetto Al. Do we know the costs of what we prescribe? A study on awareness of cost of drugs and devices among ICU staff. Intensive Care Med. 1998;24(11):1194–8. doi: 10.1007/s001340050744.PubMedCrossRefGoogle Scholar
  28. 28.
    Horwitz LI, Kosiborod M, Lin Z, Krumholz HM. Changes in outcomes for internal medicine inpatients after work-hour regulations. Ann Intern Med. 2007;147(2):97–103.PubMedGoogle Scholar
  29. 29.
    Alexander GC, Casalino LP, Meltzer DO. Physician–patient communication about out-of-pocket prescription costs. JAMA. 2003;290(7):953–8. doi: 10.1001/jama.290.7.953.PubMedCrossRefGoogle Scholar
  30. 30.
    Feng CW, Dudley RA, Brook RH, et al. Elderly patients preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 2007;55(12):1978–80.Google Scholar
  31. 31.
    Bellingham C. A simple discharge service that works. Pharm J. 2004;272:418.Google Scholar
  32. 32.
    Saunders SM, Tierney JA, Forde JM, Onorato AV, Abramson MH. Implementing a pharmacist-provided discharge counselling service. Am J Health Syst Pharm. 2003;60(11):1101, 1106, 1109.Google Scholar
  33. 33.
    Palmer HC, Armistead NS, Elnicki DM, Halperin AK, Ogershok PR, Manivannan S, et al. The effect of a hospitalist service with nurse discharge planner on patient care in an academic teaching hospital. Am J Med. 2001;111(8):627–32. doi: 10.1016/S0002-9343(01)00976-7.PubMedCrossRefGoogle Scholar
  34. 34.
    Office of the Attorney General. Florida prescription drug prices (Online). 2005. http://www.myfloridarx.com. Accessed 2 May 2008.
  35. 35.
    Michigan Department of Community Health (Online). 2006. MI prescription drug prices. http://www.michigandrugprices.com. Accessed 2 May 2008.

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.College of PharmacyQatar UniversityDohaQatar

Personalised recommendations